Latest Thrombolysis Stories
Patients who had a transient ischaemic attack (TIA), sometimes referred to as a "mini stroke", were much less likely to experience further vascular events in the first year if their care was co-ordinated by a special hospital team.
Patients who live in rural areas may have a new option for stroke care that doesn't involve traveling long distances.
Considerable regional differences exist in the treatment of patients with acute cerebral infarction.
The percentage of graduating neurology residents comfortable treating stroke with a clot-busting drug has increased dramatically over the past 10 years.
A citywide study published online in todayâ€™s issue of Stroke: Journal of the American Heart Association demonstrates racial disparities in the use of clot-busting drugs to treat acute ischemic stroke, the most common type of stroke.
In a review of nationwide hospital databases, University of Cincinnati (UC) emergency medicine and neurology researchers have found that the rate of treatment with the standard therapy for acute ischemic stroke patients has doubled since 2005.
The use of clot-busting drugs to treat acute ischemic stroke increased from 2005 through 2009 â€” but is still low.
A new treatment that treats a subset of stroke patients by combining minimally invasive surgery, an imaging technique likened to "GPS for the brain," and the clot-busting drug t-PA appears to be safe and effective.
Although so-called clot-busting drugs are commonly used in the treatment of some patients with blood clots in the lungs.
Approximately 14 percent of all strokes occur during sleep, preventing many from getting clot-busting treatment.